Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-16 of 16 for your search:
Drug:
dactinomycin
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer
Phase:
Phase IV
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and under
Sponsor:
NICHD
Protocol IDs:
PPRU 10762
, NCT00491946
2.
Phase III Randomized Study of Standard Induction Chemotherapy Comprising Vincristine, Dactinomycin, Ifosfamide, and Etoposide Followed By Consolidation Chemotherapy Comprising Vincristine, Dactinomycin, and Ifosfamide Versus High-Dose Busulfan and Melphalan Followed By Autologous Peripheral Blood Stem Cell Support With or Without Radiotherapy and/or Surgery in Patients With Tumor of the Ewing's Family
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 50
Sponsor:
NCI, Other
Protocol IDs:
EURO-EWING-INTERGROUP-EE99
, EBMT-INTERGROUP-EE99, EORTC-62981, GPOH-AUSTRIA-INTERGROUP-EE99, GPOH-GERMANY-INTERGROUP-EE99, SFOP-INTERGROUP-EE99, SWS-SAKK-INTERGROUP-EE99, CCLG-INTERGROUP-EE99, COG-AEWS0331, NCT00020566, AEWS0331
3.
Phase III Partially Randomized Study of Neoadjuvant Chemotherapy Followed By Surgery and Adjuvant Chemotherapy in Children With Wilms' Tumor
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and under
Sponsor:
Other
Protocol IDs:
SIOP-WT-2001
, SFOP-SIOP-WT-2001, CCLG-SIOP-WT-2001, GPOH-GERMANY-SIOP-WT-2001, EU-20208, NCT00047138
4.
Phase III Study of Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiotherapy in Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 50
Sponsor:
NCI
Protocol IDs:
COG-ARST0331
, NCT00075582, ARST0331
5.
Phase III Study of Adjuvant Vincristine, Dactinomycin and Doxorubicin Hydrochloride With or Without Radiotherapy or Observation Only in Younger Patients Who are Undergoing Nephrectomy for Newly Diagnosed Stage I-III Favorable Histology Wilms' Tumor
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 30 at diagnosis
Sponsor:
NCI
Protocol IDs:
COG-AREN0532
, AREN0532, NCT00352534
6.
Phase III Randomized Study of Vincristine, Dactinomycin, and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan Hydrochloride in Combination With Radiotherapy in Patients With Newly Diagnosed, Intermediate-Risk Rhabdomyosarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 50
Sponsor:
NCI
Protocol IDs:
COG-ARST0531
, NCT00354835, ARST0531
7.
Phase III Study of Combination Chemotherapy With or Without Radiotherapy in Patients With Newly Diagnosed Stage III or IV Favorable Histology Wilms' Tumor
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 30
Sponsor:
NCI
Protocol IDs:
COG-AREN0533
, AREN0533, NCT00379340
8.
Phase III Randomized Study of Ifosfamide, Vincristine, and Dactinomycin With or Without Doxorubicin in Pediatric Patients With Non-Metastatic Rhabdomyosarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 21
Sponsor:
Other
Protocol IDs:
CCLG-EPSSG-RMS-2005
, EU-20639, EUDRACT-2005-000217-35, UKCCSG-RMS-2005, NCT00379457
9.
Phase III Study of Combination Chemotherapy and Surgery in Young Patients With Bilateral, Multicentric, or Bilaterally Predisposed Unilateral Wilms Tumor
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 30 at initial diagnosis
Sponsor:
NCI
Protocol IDs:
COG-AREN0534
, AREN0534, NCT00945009
10.
Study in Localized and Disseminated Ewing Sarcoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
4 to 50
Sponsor:
Other
Protocol IDs:
108128
, EudraCT number: 2008-003658-13, NCT00987636
11.
Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors
Phase:
Phase III
Type:
Tissue collection/Repository, Treatment
Status:
Active
Age:
No age specified
Sponsor:
Other
Protocol IDs:
2009-0232
, NCT01014767
12.
Phase II Study of Intensive Chemotherapy Comprising Vincristine, Dactinomycin, and Cyclophosphamide Followed By Vincristine and Dactinomycin in Patients With Lower-Risk Embryonal Rhabdomyosarcoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Under 18
Sponsor:
Other
Protocol IDs:
JRSG-UHA-PED03-02
, NCT00245089
13.
Phase II Study of a Shortened Treatment Schedule of Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiotherapy in Patients With Low-Risk Embryonal Rhabdomyosarcoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Under 18
Sponsor:
Other
Protocol IDs:
JRSG-UHA-PED03-01
, NCT00245141
14.
Phase II Study of Combination Chemotherapy, Radiotherapy, and/or Surgery in Patients With High-Risk Renal Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Under 30
Sponsor:
NCI
Protocol IDs:
COG-AREN0321
, AREN0321, NCT00335556
15.
Study of the Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics of Dactinomycin and Vincristine in Pediatric Patients With Cancer
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Under 17
Sponsor:
NCI
Protocol IDs:
COG-ADVL06B1
, ADVL06B1, NCT00674193
16.
Pilot Study of Temozolomide and Cixutumumab in Combination With Intensive Multi-Agent Interval Compressed Chemotherapy in Patients With High-Risk Metastatic Rhabdomyosarcoma
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Under 50
Sponsor:
NCI
Protocol IDs:
COG-ARST08P1
, ARST08P1, NCT01055314
Select All on Page
Help with Results
